GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Global Study Reveals Rising Obesity Rates in Low- and Middle-Income Countries Alongside High-Income Nations

by GOAI
Share To

Recent findings highlight the increasing prevalence of overweight and obesity among adults worldwide, affecting both developed and developing countries. Data from the IMPACT-O Study provides insights into this global health issue, examining its scope and implications across various regions. The study identifies significant trends in weight-related health concerns, emphasizing their widespread nature and potential consequences for public health systems globally.

The research outlines a steady rise in adult overweight and obesity rates over recent years, with notable growth observed in low- and middle-income countries alongside traditionally high rates in wealthier nations. The study explores contributing factors such as dietary habits, physical activity levels, urbanization, socioeconomic conditions, and access to healthcare resources. It also examines the associated risks of chronic diseases like diabetes, cardiovascular conditions, and other obesity-related illnesses. These findings underscore the complexity of addressing this issue on a global scale while providing valuable data for policymakers aiming to mitigate its impact.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top